Mode
Text Size
Log in / Sign up

Tryptophan metabolism pathways and gut microbiota may influence pulmonary vascular remodeling in pulmonary hypertensionGut health and tryptophan pathways may impact pulmonary hypertension

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that tryptophan metabolism and gut microbiota may influence pulmonary vascular remodeling in pulmonary hypertension.

This systematic review explores the impact of tryptophan metabolism pathways—specifically kynurenine, serotonin, and indole—and the gut microbiota on pulmonary hypertension. The scope of the review focuses on how these metabolic pathways may influence pulmonary vascular remodeling through several physiological mechanisms.

The synthesis suggests that these pathways may influence pulmonary vascular tone, endothelial homeostasis, pulmonary arterial smooth muscle cell phenotype, inflammation, oxidative stress, and cellular metabolism. These findings indicate that tryptophan metabolism may play a role in the underlying pathophysiology of pulmonary hypertension.

While the review identifies these pathways as potential therapeutic targets, the authors note that the precise mechanisms of how tryptophan metabolism influences pulmonary vascular remodeling are not yet clarified. Clinical translation is currently limited by these gaps in mechanistic understanding.

For clinicians, these findings suggest potential future targets for pharmacological intervention in pulmonary hypertension. However, the evidence is currently focused on identifying potential pathways rather than established clinical protocols.

Living with pulmonary hypertension means dealing with high blood pressure in the lungs. This condition can make it harder to breathe and affects how the body functions every day. Scientists are looking closely at how the body processes certain nutrients to see if they can help manage these symptoms.

Researchers looked at how tryptophan metabolism works. Tryptophan is an amino acid that the body breaks down into different pathways, such as kynurenine, serotonin, and indole. These pathways, along with the gut's natural bacteria, may influence how lung blood vessels change over time. Specifically, these processes might affect inflammation, cell metabolism, and the health of the vessel lining.

While these findings point toward new ways to treat the condition, the science is still in the early stages. The exact ways these pathways influence the lungs are not yet fully clear. However, identifying these links helps doctors find new targets for future treatments to improve life for those with pulmonary hypertension.

What this means for you:
Gut health and tryptophan pathways may offer new ways to target lung blood vessel issues.

Common questions

What is the role of tryptophan in pulmonary hypertension?

Tryptophan is an amino acid that the body breaks down into different pathways, including kynurenine, serotonin, and indole. These pathways may influence how lung blood vessels change by affecting things like inflammation, cell metabolism, and the health of the vessel lining.

How does gut health affect lung health?

The gut microbiota, or the collection of bacteria in your gut, works alongside tryptophan metabolism. Together, these factors may influence pulmonary vascular tone and the health of the blood vessels in the lungs.

Are these findings ready for clinical use?

The research shows potential targets for future treatments, but the precise mechanisms of how these pathways work are not yet fully clarified. You should speak with your doctor about current treatment options.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
Pulmonary hypertension (PH) comprises a group of cardiopulmonary disorders characterized by a sustained increase in pulmonary vascular resistance and pulmonary vascular remodeling, with disease progression potentially leading to right heart failure and death. Current therapies can improve symptoms and hemodynamics in some patients, but effective means of reversing established structural pulmonary vascular remodeling remain lacking. Gut microbial dysbiosis, intestinal barrier injury, and altered microbial metabolism have been proposed to contribute to the development and progression of PH. Tryptophan metabolism is jointly regulated by host tissues, immune cells, and gut microorganisms and serves as a key hub linking the host and its commensal microbiota. The kynurenine, serotonin, and indole pathways may participate in pulmonary vascular remodeling by influencing pulmonary vascular tone, endothelial homeostasis, pulmonary arterial smooth muscle cell phenotype, inflammation, oxidative stress, and cellular metabolism, although the precise mechanisms remain to be clarified. This review systematically summarizes current evidence on the involvement of the gut microbiota and tryptophan metabolism in pulmonary vascular remodeling in PH, with emphasis on the available evidence, potential therapeutic targets, and prospects for clinical translation, thereby providing a basis for further investigation of the metabolic regulation of PH and the development of new intervention strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.